[Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using endorectal 1H magnetic resonance spectroscopy]
- PMID: 8551711
- DOI: 10.5980/jpnjurol1989.86.1673
[Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using endorectal 1H magnetic resonance spectroscopy]
Abstract
Background: We evaluate the usefulness of 1H endorectal resonance spectroscopy to characterize prostate pathology.
Methods: With an endorectal surface coil we have studied 20 individuals with normal (1), benign hyperplastic (9) and malignant (10) prostates.
Results: The major findings of our studies were that the patients with cancer have a significantly lower citrate-to-choline ratio (cit/cho) and creatin-to-choline ratio (cre/cho) than the patients with BPH (p < 0.05). There is well correlation between cit/cho and gland-to-stroma ratio of the BPH tissue as well as histological grade of the cancer tissue. 1H spectroscopy offers the advantages of differential diagnosis between benign and malignant prostates. We, however, failed to demonstrate cancer in 2 cases; the lesion was too small in one case, and out of the region of interest in the other. It is necessary that the foci in the prostate is at least 1.5 X 1.5 X 1.5 cm3 of the volume in order to obtain genuine spectrogram of carcinoma.
Conclusion: Endorectal 1H magnetic resonance spectroscopy can characterize metabolic differences between the normal and malignant prostate.
Similar articles
-
Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.J Urol. 1991 Jul;146(1):66-74. doi: 10.1016/s0022-5347(17)37716-9. J Urol. 1991. PMID: 1711587
-
In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.Magn Reson Imaging. 1998 Dec;16(10):1281-8. doi: 10.1016/s0730-725x(98)00110-6. Magn Reson Imaging. 1998. PMID: 9858286
-
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.Urology. 1995 Mar;45(3):459-66. doi: 10.1016/S0090-4295(99)80016-8. Urology. 1995. PMID: 7533458 Clinical Trial.
-
[Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].Clin Ter. 1996 Jan-Feb;147(1-2):51-66. Clin Ter. 1996. PMID: 8767956 Review. Italian.
-
Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology.MAGMA. 2008 Nov;21(6):423-34. doi: 10.1007/s10334-008-0136-0. Epub 2008 Sep 17. MAGMA. 2008. PMID: 18797949 Review.
Cited by
-
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.Neoplasia. 2000 Jan-Apr;2(1-2):166-89. doi: 10.1038/sj.neo.7900081. Neoplasia. 2000. PMID: 10933075 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical